Search

Your search keyword '"Dibilio, Edoardo"' showing total 12 results
Start Over Author "Dibilio, Edoardo"
12 results on '"Dibilio, Edoardo"'

1. Oncological results and cancer control definition in focal therapy for Prostate Cancer: a systematic review

Author

Nicoletti, Rossella, Alberti, Andrea, Castellani, Daniele, Yee, Chi Hang, Zhang, Kai, Poon, Darren M. C., Chiu, Peter Ka-Fung, Campi, Riccardo, Resta, Giulio Raffaele, Dibilio, Edoardo, Pirola, Giacomo Maria, Chiacchio, Giuseppe, Fuligni, Demetra, Brocca, Carlo, Giulioni, Carlo, De Stefano, Virgilio, Serni, Sergio, Gauhar, Vineet, NG, Chi Fai, Gacci, Mauro, and Teoh, Jeremy Yuen Chun

Published
2024
Full Text
View/download PDF

2. Functional outcomes and safety of focal therapy for prostate cancer: a systematic review on results and patient-reported outcome measures (PROMs)

Author

Nicoletti, Rossella, Alberti, Andrea, Castellani, Daniele, Yee, Chi Hang, Zhang, Kai, Poon, Darren M. C., Chiu, Peter Ka-Fung, Campi, Riccardo, Resta, Giulio Raffaele, Dibilio, Edoardo, Pirola, Giacomo Maria, Chiacchio, Giuseppe, Fuligni, Demetra, Brocca, Carlo, Giulioni, Carlo, De Stefano, Virgilio, Serni, Sergio, Gauhar, Vineet, Ng, Chi Fai, Gacci, Mauro, and Teoh, Jeremy Yuen Chun

Published
2024
Full Text
View/download PDF

3. Surgical and Oncological Outcomes of Level III–IV Versus Level I–II Inferior Vena Cava Thrombectomy: A Decennial Experience of a High-Volume European Referral Center

Author

Dell’Oglio, Paolo, Tappero, Stefano, Mandelli, Giuditta, Saccucci, Tommaso, Dibilio, Edoardo, Caviglia, Alberto, Vecchio, Enrico, Maltzman, Ofir, Martiriggiano, Marco, Olivero, Alberto, Secco, Silvia, Barbieri, Michele, Di Trapani, Dario, Buratto, Carlo, Palagonia, Erika, Strada, Elena, Napoli, Giancarlo, Petralia, Giovanni, Bocciardi, Aldo Massimo, and Galfano, Antonio

Published
2024
Full Text
View/download PDF

4. Patient-reported Outcome Measures and Experience Measures After Active Surveillance Versus Radiation Therapy Versus Radical Prostatectomy for Prostate Cancer: A Systematic Review of Prospective Comparative Studies

Author

Alberti, Andrea, Nicoletti, Rossella, Castellani, Daniele, Yuan, Yuhong, Maggi, Martina, Dibilio, Edoardo, Resta, Giulio Raffaele, Makrides, Pantelis, Sessa, Francesco, Sebastianelli, Arcangelo, Serni, Sergio, Gacci, Mauro, De Nunzio, Cosimo, Teoh, Jeremy Y.C., and Campi, Riccardo

Published
2024
Full Text
View/download PDF

5. Surgical and Oncological Outcomes of Level III–IV Versus Level I–II Inferior Vena Cava Thrombectomy: A Decennial Experience of a High-Volume European Referral Center.

Author

Dell'Oglio, Paolo, Tappero, Stefano, Mandelli, Giuditta, Saccucci, Tommaso, Dibilio, Edoardo, Caviglia, Alberto, Vecchio, Enrico, Maltzman, Ofir, Martiriggiano, Marco, Olivero, Alberto, Secco, Silvia, Barbieri, Michele, Di Trapani, Dario, Buratto, Carlo, Palagonia, Erika, Strada, Elena, Napoli, Giancarlo, Petralia, Giovanni, Bocciardi, Aldo Massimo, and Galfano, Antonio

Abstract

Background: In patients with renal cell carcinoma (RCC) the role of the extent of tumor thrombus into the inferior vena cava (IVC) has never been addressed from a surgical and oncologic standpoint. This study aims to evaluate differences between level III–IV versus level I–II patients concerning peri- and postoperative morbidity, additional treatments and long-term oncological outcomes. Patients and Methods: Overall, 40 patients with RCC underwent radical nephrectomy (RN) with IVC thrombectomy at a single European institution between 2010 and 2023. Complications were reported according to the European Union (EAU) guidelines recommendations. Spider chart served as graphical depiction of surgical and oncologic outcomes. Results: Overall, 22 (55%) and 18 (45%) patients harbored level III–IV and I–II IVC thrombus. Level III–IV patients experienced significantly higher rates of intraoperative transfusions (68 vs 39%), but not significantly higher rates of intraoperative complications (32% vs 28%). Level III–IV patients had significantly higher rates of postoperative transfusions (82% vs 33%) and Clavien Dindo ≥3 complications (41% vs 15%). In level III–IV versus level I–II patients, median follow up was 482 and 1070 days, the rate of distant recurrence was 59% and 50%, the rate of systemic progression was 27% and 13%, and the rate of additional treatment/s was 64% and 61%, respectively (all p values > 0.05). Overall survival was 36% in level III–IV patients and 67% in level I–II (p = 0.001). Conclusions: Our findings suggest that patients with level III–IV RCC who are candidates for IVC thrombectomy should be counselled about the higher likelihood of postoperative severe adverse events and worse overall survival relative to level I–II counterparts. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

6. Morbidity of Transrectal MRI-Fusion Targeted Prostate Biopsy at a Tertiary Referral Academic Centre: An Audit to Guide the Transition to the Transperineal Approach

Author

Alberti, Andrea, primary, Nicoletti, Rossella, additional, Polverino, Paolo, additional, Rivetti, Anna, additional, Dibilio, Edoardo, additional, Resta, Giulio Raffaele, additional, Makrides, Pantelis, additional, Caneschi, Corso, additional, Cifarelli, Andrea, additional, D’Amico, Antonino, additional, Moscardi, Luisa, additional, Lo Re, Mattia, additional, Peschiera, Federico, additional, Gallo, Maria Lucia, additional, Pecoraro, Alessio, additional, Sebastianelli, Arcangelo, additional, Masieri, Lorenzo, additional, Gacci, Mauro, additional, Serni, Sergio, additional, Campi, Riccardo, additional, and Sessa, Francesco, additional

Published
2023
Full Text
View/download PDF

7. Urinary Continence Recovery after Robotic Radical Prostatectomy without Anterior or Posterior Reconstruction: Experience from a Tertiary Referral Center

Author

Sessa, Francesco, primary, Nicoletti, Rossella, additional, Pecoraro, Alessio, additional, Polverino, Paolo, additional, Rivetti, Anna, additional, Conte, Francesco Lupo, additional, Lo Re, Mattia, additional, Belmonte, Mario, additional, Alberti, Andrea, additional, Dibilio, Edoardo, additional, Gallo, Maria Lucia, additional, Manera, Alekseja, additional, Gacci, Mauro, additional, Sebastianelli, Arcangelo, additional, Vignolini, Graziano, additional, Serni, Sergio, additional, Campi, Riccardo, additional, and Li Marzi, Vincenzo, additional

Published
2023
Full Text
View/download PDF

8. 50 - Functional outcomes of total intracorporeal Y neobladder robot-assisted-radical-cystectomy in tertiary center: Urodynamics findings

Author

Checcucci, Enrico, Manfredi, Matteo, Sica, Michele, Amparore, Daniele, Piana, Alberto, Piramide, Federico, De Cillis, Sabrina, Pecoraro, Angela, Verri, Paolo, Granato, Stefano, Piscitello, Stefano, Ola, Luciano, Zamengo, Davide, Dibilio, Edoardo, Cattaneo, Giovanni, Poggio, Massimiliano, Fiori, Cristian, and Porpiglia, Francesco

Published
2022
Full Text
View/download PDF

9. PD60-09 LAPAROSCOPIC VERSUS ROBOT-ASSISTED RADICAL PROSTATECTOMY: TEN-YEAR OUTCOME OF A PROSPECTIVE RANDOMISED TRIAL

Author

Checcucci, Enrico, primary, Alladio, Eugenio, additional, De Cillis, Sabrina, additional, Granato, Stefano, additional, Amparore, Daniele, additional, Piana, Alberto, additional, Piramide, Federico, additional, Volpi, Gabriele, additional, Sica, Michele, additional, Verri, Paolo, additional, Carbonaro, Beatrice, additional, Meziere, Juliette, additional, Zamengo, Davide, additional, Della Corte, Marcello, additional, Dibilio, Edoardo, additional, Pecoraro, Angela, additional, Cattaneo, Giovanni, additional, Di Dio, Michele, additional, Manfredi, Matteo, additional, and Porpiglia, Francesco, additional

Published
2022
Full Text
View/download PDF

10. PD17-11 COMPARISON BETWEEN TARGET VS TARGET PLUS STANDARD BIOPSY FOR PROSTATE CANCER DIAGNOSIS IN BIOPSY NAÏVE PATIENTS: A RANDOMIZED CONTROLLED TRIAL

Author

Checcucci, Enrico, primary, Manfredi, Matteo, additional, De Cillis, Sabrina, additional, Amparore, Daniele, additional, Piramide, Federico, additional, Piana, Alberto, additional, Volpi, Gabriele, additional, Sica, Michele, additional, Verri, Paolo, additional, Granato, Stefano, additional, Piscitello, Stefano, additional, Burgio, Mariano, additional, Luciano, Ola, additional, Carbonaro, Beatrice, additional, Zamengo, Davide, additional, Quarà, Alberto, additional, Della Corte, Marcello, additional, Dibilio, Edoardo, additional, Alessio, Paolo, additional, Pecoraro, Angela, additional, Sturia, Ilaria, additional, Migliaretti, Giuseppe, additional, Fiori, Cristian, additional, De Luca, Stefano, additional, and Porpiglia, Francesco, additional

Published
2022
Full Text
View/download PDF

11. MP58-05 URINARY SMART TEST FOR EARLY DETECTION OF PROSTATE CANCER

Author

Occhipinti, Sergio, primary, Amparore, Daniele, additional, Granato, Stefano, additional, Checcucci, Enrico, additional, Piramide, Federico, additional, De Cillis, Sabrina, additional, Piana, Alberto, additional, Volpi, Gabriele, additional, Verri, Paolo, additional, Sica, Michele, additional, Piscitello, Stefano, additional, Carbonaro, Beatrice, additional, Burgio, Mariano, additional, Meziere, Juliette, additional, Cisero, Edoardo, additional, Dibilio, Edoardo, additional, Busacca, Giovanni, additional, Manfredi, Matteo, additional, Fiori, Cristian, additional, and Porpiglia, Francesco, additional

Published
2022
Full Text
View/download PDF

12. Use of a Schelin catheter for transurethral intraprostatic anesthesia (TUIA) prior to iTIND procedure

Author

Secco, Silvia, Olivero, Alberto, Longoni, Mattia, Dell’Oglio, Paolo, Tappero, Stefano, Dibilio, Edoardo, Saccucci, Tommaso, Siena, Giampaolo, Bocciardi, Aldo Massimo, Galfano, Antonio, and Cindolo, Luca

Abstract

Background/Objectives: Endorsing the principles of minimal invasiveness in benign-prostatic hyperplasia (BPH) surgery, we conducted the first evaluation of transurethral intraprostatic anesthesia (TUIA) using Schelin catheter® (SC) prior to iTIND positioning. Subjects/Methods: Of 23 patients enrolled, 11 (48%) received TUIA via SC whereas the remaining underwent standard anesthesia protocol. Pain was assessed using visual analogue scale (VAS). Results: No differences between cohorts were observed for pain during the device implantation and removal. Conversely, significantly lower median VAS scores were reported at 24- (1.0 vs. 3.0) and 48- (1.0 vs. 2.5) hour follow-up favoring TUIA. Conclusions: SC TUIA offers effective pain control during iTIND procedures, supporting its use in outpatient settings.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results